(Q31128115)

English

Characterization of amyloid beta peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Characterization of amyloid beta peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

1 reference

based on heuristic

inferred from title

author name string

Stefan Pype

1

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Dieder Moechars

2

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Lieve Dillen

3

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Marc Mercken

4

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

language of work or name

0 references

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Journal of Neurochemistry

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

84

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

602-609

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

BACE1 is the major beta-secretase for generation of Abeta peptides by neurons

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

Transgenic mouse models of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

The functional gamma-secretase inhibitor prevents production of amyloid beta 1-34 in human and murine cell lines

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01556.X

21 January 2018

Identifiers

10.1046/J.1471-4159.2003.01556.X

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31128115&oldid=1951320359"